Engineered Cytisine Derivative Disrupts Redox Balance to Kill Lung Cancer Cells
Researchers engineered a thiourea-bridged cytisine derivative, YU-C-ThioU-9, that overwhelms the antioxidant defenses of lung cancer cells by disrupting Nrf2-Keap1 and ...
